FILE - A view of the U.S. Food and Drug Administration headquarters in Silver Spring, Maryland, taken on October 14, 2015. (AP Photo/Andrew Harnik, File)
In a significant step forward for women’s health, the U.S. Food and Drug Administration has approved the first-ever at-home cervical cancer testing kit. This new option allows women to collect a sample by themselves at home, eliminating the need for a clinic visit. The product, named the Teal Wand, was developed by San Francisco-based medical device company Teal Health.
The kit is designed to detect human papillomavirus (HPV), which is the leading cause of cervical cancer. Until now, HPV screenings and Pap smears were only done in medical clinics. But with this approval, women can now collect a sample from the privacy of their home and send it to a lab for analysis.
To use the kit, the user inserts a swab or soft brush into the vagina, rotates it gently to collect cells, and places it in a secure tube. That sample is then mailed to a lab for testing. While the process sounds simple, a prescription is still required. Customers can obtain this through a virtual consultation with a healthcare provider connected with Teal Health.
The launch is beginning in California, where Teal Health will make the kit available starting next month. The company has also stated that it plans to expand to other states in the near future. Teal Health is currently in discussions with health insurance providers to make the kit more widely accessible through coverage.
HPV is one of the most common sexually transmitted infections and often goes away on its own. However, when it doesn’t, it can silently lead to cervical cancer over time. According to health experts, most cervical cancer cases occur in women who do not undergo regular screenings. That’s why this new home-testing option could be a game-changer—especially for women who skip clinic visits due to time, embarrassment, or lack of access to care.
The approval follows a 2023 recommendation from a federal health panel that encouraged self-collection of HPV samples to improve overall screening rates. While the FDA had previously approved two older HPV tests for self-collection, those still required patients to go to a healthcare setting. The Teal Wand is the first product to break that barrier by enabling sample collection entirely at home.
Teal Health says the device is simple to use and designed to be comfortable. The company also emphasizes that this kit is not meant to replace routine checkups but to offer an alternative for those who find it difficult to visit a clinic.
As the kit rolls out across the U.S., it could open the door for more innovations in at-home health testing—offering women more control over their health, one sample at a time.
